Pre-clinical data on HOOKIPA’s alternating 2-vector cancer therapeutics published in Cell Reports Medicine

NEXT STORY
Apollomics, Inc. Announces Successful Enrollment of First Patient Into Phase 1 Clinical Trial of APL-106 (Uproleselan Injection) in China
PREV STORY
Sotherly Hotels Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

G1 Therapeutics to Present at Wedbush PacGrow Healthcare Conference on August 14, 2018

RESEARCH TRIANGLE PARK, N.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: ...

author_avatar
NASDAQ Market News

Baptist Health South Florida Hospitals Named Among the Best in the Nation by U.S. News & World Report

Miami, FL, Aug. 08, 2017 (GLOBE NEWSWIRE) -- MIAMI, FL – August 8, 2017 ...

author_avatar
NASDAQ Market News

CytomX Announces First Quarter 2017 Financial Results

SOUTH SAN FRANCISCO, Calif., May 05, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

author_avatar
NASDAQ Market News